Holubiak Myron Z
SEC-identified person · CIK 1199080 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tenx Keane Acquisition TENKU | Director · Secretary | filed 2024 - 2025 |
| Citius Pharmaceuticals, Inc. CTXR | Director · Vice Chairman | filed 2015 - 2025 |
| Ventrus Biosciences INC VTUS | Director | filed 2010 - 2021 |
| Option Care Health, Inc. OPCH | Director | filed 2006 - 2016 |
| Intellicell Biosciences, Inc. SVFC | Director | filed 2013 - 2013 |
| Nastech Pharmaceutical CO INC NSTK | Director | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.